Compare Lustrum:Delta-Fly Pharma,Inc.:4598

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Delta-Fly Pharma,Inc. Go to web site 4598 Medicals 東証グロース March 1, 2000 2018.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Delta-Fly Pharma,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Delta-Fly Pharma,Inc. Balance Sheet 2024年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2023年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2022年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2021年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents
(Percent)
1,417up
(96.1%)up
844down
(93.1%)down
1,268down
(95.8%)down
2,089up
(96.6%)up
1,944
(89.9%)
Other Current AssetsHelp
(Percent)
16down
(1.1%)down
22up
(2.4%)up
12down
(0.9%)down
27down
(1.2%)down
172
(7.9%)
Tangible Fixed AssetsHelp
(Percent)
38down
(2.6%)down
39down
(4.3%)up
40down
(3.0%)up
42down
(1.9%)down
43
(2.0%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
0down
(0.0%)down
0
(0.0%)
Investments and OthersHelp
(Percent)
3up
(0.2%)down
2down
(0.2%)down
4down
(0.3%)up
4up
(0.2%)up
3
(0.2%)
Total AssetsHelp
(Percent)
1,474
(100%)
907
(100%)
1,324
(100%)
2,161
(100%)
2,162
(100%)
Total Current LiabilitiesHelp
(Percent)
241up
(16.4%)up
116up
(12.7%)up
91up
(6.9%)up
82down
(3.8%)down
106
(4.9%)
Total Long-term LiabilitiesHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Shareholder's EquityHelp
(Percent)
1,233up
(83.6%)down
791down
(87.3%)down
1,233down
(93.1%)down
2,079up
(96.2%)up
2,056
(95.1%)
Total LiabilitiesHelp
(Percent)
1,474
(100%)
907
(100%)
1,324
(100%)
2,161
(100%)
2,162
(100%)

Delta-Fly Pharma,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Delta-Fly Pharma,Inc. Profit and Loss Account 2024年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2023年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2022年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2021年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales
(Percent)
-
(100%)
0
(100%)
300
(100%)
300
(100%)
100
(100%)
Total Sales
(Percent)
-
(100%)
0
(100%)
300
(100%)
300
(100%)
100
(100%)
Cost of SalesHelp
(Percent)

-

-

-

-

-
Other Costs and RevenueHelp 0
-
1,329up
1,267up
(422.4%)up
1,163down
(387.5%)down
1,656
(1,655.8%)
Total CostsHelp 0 1,329 1,267 1,163 1,656
Net RevenueHelp
-

-

-

-

-
Earnings Before TaxHelp
-
-1,326down
-964down
(-321.4%)down
-859up
(-286.5%)up
-1,552
(-1,552.2%)
Net IncomeHelp
-
-1,329down
-967down
(-322.4%)down
-863up
(-287.5%)up
-1,556
(-1,555.8%)
当期純利益 - -1,329 -967 -863 -1,556

Delta-Fly Pharma,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Delta-Fly Pharma,Inc. Cash Flow Statement 2024年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2023年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2022年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2021年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
-1,280up
(-69.1%)up
-1,303down
(-99.7%)up
-940down
(-100.0%)down
-727up
(-83.0%)up
-1,649
(-99.1%)
Investing Cash Flow(ICF)Help
(Percent)

-
0up
(0.0%)up
-0up
(0.0%)up
-1
(-0.1%)down
-1
(0.0%)
Financing Cash FlowHelp
(Percent)
1,853up
(100.0%)up
883up
(67.5%)up
120down
(12.7%)down
875up
(100.0%)up
100
(6.0%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)

-
-4down
(-0.3%)down
1up
(0.1%)up
-3up
(-0.4%)up
-15
(-0.9%)
Net Increase and Decrease in Cash and Cash Equivalentsn 573up
(30.9%)up
-424up
(-32.5%)up
-820down
(-87.2%)down
145up
(16.5%)up
-1,565
(-94.0%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Delta-Fly Pharma,Inc.

Company where related level is highHelp

Fuji Pharma Co.,Ltd.
ASKA Pharmaceutical Co.,Ltd.
TOWA PHARMACEUTICAL CO.,LTD.
NIPPON CHEMIPHAR CO.,LTD.
Cuorips Inc.
OncoTherapy Science,Inc.
MEDICAL & BIOLOGICAL LABORATORIES CO.
MediciNova,Inc
JCR Pharmaceuticals Co.,Ltd.
NANO MRNA Co., Ltd.